24.04.2024 - Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In-depth analysis of VIVIAD Phase 2b results is ongoing, including pre-specified and exploratory endpoints; findings to date .
/PRNewswire/ On February 19, 2024, the Journal of American Medical Association•Neurology (JAMA NEUROLOGY, IF: 29.0) published online the key findings of a.
On February 19, 2024, the Journal of American Medical Association?Neurology published online the key findings of a phase III clinical study investigating Sanbexin® sublingual tablets for the.
Findings of a Phase III Clinical Study of Sanbexin Sublingual Tablets Published in JAMA philippinetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philippinetimes.com Daily Mail and Mail on Sunday newspapers.
Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.